2026 Hemophilia Fellowship – United States
This grant funds U.S. institutions to develop multidisciplinary, equitable hemophilia training programs with mentorship, shared decision making, and capstone projects to advance clinical practice and education.
Funder: Pfizer Inc.
Due Dates: June 30, 2026 (extended submission deadline; 23:59 EST; late applications not reviewed)
Funding Amounts: Up to $100,000 for a one-year institution-based fellowship; salary and benefits only; no overhead/indirect costs.
Summary: Supports U.S. institutions to advance hemophilia care through equitable education, shared decision making, and multidisciplinary training.
Key Information: Applications submitted after the deadline will not be reviewed.
Description
This competitive fellowship grant supports U.S.-based academic institutions in developing and implementing structured, institution-based training programs in hemophilia care. The program emphasizes equitable education, patient-centered shared decision making, and multidisciplinary team-based approaches, particularly for underserved populations. The fellowship is designed to address the educational needs and gaps in hemophilia care within the context of rapidly evolving treatment options. Funded programs are expected to include mentorship, SDM training, and a practical capstone project, ultimately strengthening workforce capacity and advancing clinical practice, research, and education in hemophilia.
